No Data
No Data
Kane Biotech Receives ISO 13485:2016 MDSAP Quality Certification
Provides access to Canadian, Australian, New Zealand and Brazilian marketsWINNIPEG, Manitoba, July 17, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE; OTCQB:KNBIF) ("Kane Biotech" or "Kane")
Kane Biotech Announces Issuance of Restricted Share Units
WINNIPEG, Manitoba, July 15, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE; OTCQB:KNBIF), (the "Company" or "Kane Biotech"), today announces that it has issued 4,213,133 restricted share
Kane Biotech Q1 Loss Widens Despite Revenue Gains; to Report a Q2 Gain Following Sale of STEM Animal Health
Kane Biotech (KNE.V) Thursday said its first-quarter loss widened even as revenue rose by 39%.. The company, which makes products to prevent and remove microbial biofilms, said it lost $1.4 million, o
Kane Biotech to Release First Quarter 2024 Financial Results on May 23, 2024
WINNIPEG, Manitoba, May 16, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the "Company" or "Kane Biotech"), a biotechnology company engaged in the research, development and c
Kane Biotech Expands Its Wound Care Portfolio With Patented Schultz Biofilm Wound Map
Named in Honour of the late Dr. Greg Schultz, Former Professor Emeritus at the University of Florida and Chief Science Officer of Kane BiotechWINNIPEG, Manitoba, May 15, 2024 (GLOBE NEWSWIRE) -- Kan
Kane Biotech to Host Investor Webinar
What the sale of STEM Animal Health means for Kane going forward – Thursday April 18th, 2024 at 4:15pm Eastern TimeWINNIPEG, Manitoba, April 16, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KN